Summary & Overview
CPT 3294F: Brief Clinical Description
CPT code 3294F is listed without a descriptive summary in the provided source. This CPT code represents a clinical service or performance measure within the Current Procedural Terminology system; the specific clinical intent and billing attributes are not available in the input. Nationally, clear definitions for CPT codes matter because they drive claims processing, provider documentation, and payer policy across public and private programs.
Key payers discussed in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s role in billing workflows, the payers typically involved in coverage determinations, and where to find missing clinical and coding details. The publication outlines common benchmarking topics and policy considerations relevant to CPT-coded services, including reimbursement alignment, documentation standards, and potential impacts on clinical reporting.
The report is intended for coding professionals, billing managers, and policy analysts who need a concise reference when a code’s description is unavailable. It highlights the need to consult payer-specific policies and authoritative CPT resources for definitive clinical definitions and billing instructions. Data not available in the input is noted where specifics are missing.
Billing Code Overview
CPT code 3294F has no summary available in the source description. Data not available in the input.
Service Type: Data not available in the input.
Typical Site of Service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with progressive dyspnea, chronic cough, or an abnormal chest imaging study suggesting a suspected pulmonary nodule or localized parenchymal disease requiring diagnostic tissue sampling. The patient presents to an outpatient interventional pulmonology clinic or a hospital bronchoscopy suite. After pre-procedure evaluation, including history, medication reconciliation, coagulation assessment, and informed consent, the patient undergoes flexible bronchoscopy with targeted transbronchial lung biopsy under moderate sedation or monitored anesthesia care. The workflow includes airway inspection, localization of the lesion via fluoroscopy or radial endobronchial ultrasound if needed, sampling with biopsy forceps or cryoprobe, specimen handling for pathology and microbiology, hemostasis assessment, and post-procedure observation for complications such as pneumothorax or bleeding. Discharge instructions and pathology follow-up are arranged, with possible chest radiograph post-procedure based on institutional protocol and clinical risk factors.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management (E/M) service by the same physician on the day of a procedure | Use when a distinct E/M visit is documented the same day as the procedure |
26 | Professional component | Use if billing only the physician interpretation portion when global service split exists